E. Bretschneider et al., Evidence for functionally active protease-activated receptor-4 (PAR-4) in human vascular smooth muscle cells, BR J PHARM, 132(7), 2001, pp. 1441-1446
1 This study investigates, whether in addition to the protease-activated re
ceptor-1 (PAR-1), PAR-4 is present in vascular smooth muscle cells (SMC) of
the human saphenous vein and whether this receptor is functionally active.
PAR-1 and PAR-4 are stimulated by thrombin and by the synthetic peptides S
FLLRN and GYPGQV, respectively.
2 mRNAs for both, PAR-1 and PAR-4, were detected in the SMC by using revers
e transcriptase polymerase chain reaction (RT-PCR).
3 Treatment of the SMC with GYPGQV (200 muM) resulted in a transient increa
se in free intracellular calcium. This calcium signal was completely abolis
hed after a preceding challenge with thrombin (10 nM), indicating homologou
s receptor desensitization.
4 Stimulation of the SMC with 10 nM thrombin or 200 muM SFLLRN caused a tim
e-dependent activation of the extracellular signal-regulated kinases-1/2 (E
RK-1/2) with a maximum at 5 min. In contrast, 100 nM thrombin as well as 20
0 muM of GYPGQV induced a prolonged phosphorylation of ERK-1/2 with a maxim
um at 60 min. These data suggest that PAR-1 and PAR-4 are activated by thro
mbin at distinct concentrations and with distinct kinetics.
5 GYPGQV stimulated [H-3]-thymidine incorporation in SMC. At 500 muM, the p
eptide increased DNA synthesis 2.5 fold above controls. A comparable mitoge
nic effect was obtained after stimulation of the SMC by 10 nM thrombin or 1
00 muM SFLLRN, respectively.
6 These data indicate that a functionally active PAR-4 is present in SMC an
d, in addition to PAR-1, might contribute to thrombin-induced mitogenesis.